The efficacy of topical thiocolchicoside (Muscoril®) in the treatment of acute cervical myofascial pain syndrome: A single-blind, randomized, prospective, phase IV clinical study

Agri

Volumn 21, Issue 3, 2009, Pages 95-103

  Ketenci, Ayşegül ^a   Basat, Hande ^a   Esmaeilzadeh, Sina ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Local injection; Medical treatment; Muscle relaxant; Myofascial pain syndrome; Trigger point

Indexed keywords

COLCHICINE; DRUG DERIVATIVE; MUSCLE RELAXANT AGENT; THIOCOLCHICOSIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; MYOFASCIAL PAIN; OINTMENT; PAIN ASSESSMENT; PHASE 4 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; COLCHICINE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MYOFASCIAL PAIN SYNDROMES; NEUROMUSCULAR AGENTS; OINTMENTS; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70249088685     PISSN: 13000012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sola AE, Bonica JJ. Myofascial pain syndromes. In: Bonica JJ, editor.The management of pain. 2nd ed. Malvern: Lea & Fe- biger;1990. p. 352-367
2. Han SC, Harrison P. Myofascial pain syndrome and trigger- point management. Reg Anesth 1997;22:89-101.
3. Taylor H. The Nuprin Report. New York: Lou Harris Associates; 1985.
4. Travell JG, Simons DG. Myofascial pain and dysfunction. The Trigger Point Manual. Baltimore: Williams & Wilkins; 1992.
5. Skootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med 1989;151:157-160
6. Magni G. The epidemiology of musculoskeletal pain. In: Voeroy H, Merskey H, editors. Progress in fibromyalgia and myofascial pain. Amsterdam: Elsevier Science; 1993. p. 3-20.
7. Porta M.Treatment of myofascial pain by injection with boti- linum toxin. Bollington: Adelphi Communications Ltd; 1997.
8. Thompson JM. The diagnosis and treatment of muscle pain syndromes. In: Braddom RL, editor. Physical medicine and rehabilitation. Philadelphia: Saunders Company; 1996. p. 893-914.
9. Simons DG. Myofascial pain syndromes: where are we? Where are we going? Arch Phys Med Rehabil 1988;69(3 Pt 1):207-212
10. Simons DG, Travell JG. Myofascial pain syndromes. In: Wall PD, Melzack R, editors. Textbook of Pain. New York: Churchill Livingstone; 1989. p. 368-385
11. Ojala T, Arokoski JP, Partanen J. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial. Clin J Pain 2006;22:90-96
12. Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW, Jensen TS. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology 2006;67:241-245
13. Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005;25:604-611
14. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85:101-105
15. Patat A, Klein MJ. Effects of acute and repeated doses of two muscle relaxants chlormezanone and thiocolchicoside, on vigilance and psychomotor performance of healthy volunteers. Hum Psychopharmacol 1991;6:285-292
16. Janbroers JM. Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle-relaxant with anti-inflammatory and analgesic actions. Acta Ther 1987;13:221-250
17. Eandi M, Genazzani E, Delia Pepa C, Basso G. Ricerca farma- coepidemiologica in fase IV sulla efficacia e tollerabilita' del prodottoMuscoril OrtTraum Oggi 1992;12:138-148
18. Marcel C, Rezvani Y, Revel M. Evaluation of thiocolchicoside as monotherapy in low back pain. Results of a randomized study versus placebo. [Article in French] Presse Med 1990;19:1133-1136
19. Ventura R, Leonardi M, Mastropaolo C, Picci M, Vescovini R. Studio clinico controllato sull'uso del thiocolchicoside nella patologia ortopedica. Ortop Traumatol Oggi 1983;3:65-73.
20. Fischer AA. Documentation of myofascial trigger points. Arch Phys Med Rehabil 1988;69:286-291
21. Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994;56:217-226
22. Baldry P. Management of myofascial trigger point pain. Acu- punct Med 2002;20:2-10.
23. Dalpiaz AS, Lordon SP, Lipman AG. Topical lidocaine patch therapy for myofascial pain. J Pain Palliat Care Pharmacother 2004;18:15-34.
24. Dalpiaz AS, Dodds TA. Myofascial pain response to topical lidocaine patch therapy: case report. J Pain Palliat Care Pharmacother 2002;16:99-104.
25. Edwards J, Knowles N. Superficial dry needling and active stretching in the treatment of myofascial pain-a randomised controlled trial. Acupunct Med 2003;21:80-86
26. CummingsTM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 2001;82:986-992
27. Kvien TK, Viktil K. Pharmacotherapy for regional musculoskeletal pain. Best Pract Res Clin Rheumatol 2003;17:137-150
28. Ketenci A, Ozcan E, Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract 2005;59:764-770
29. Trellu M, Filali-Ansary A, Françon D, Adam R, Lluel P, Dubruc C, Thenot JP. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans. Fundam Clin Pharmacol 2004;18:493-501.
30. Frost A. Diclofenac versus lidocaine as injection therapy in myofascial pain. Scand J Rheumatol 1986;15:153-156
31. Göbel H, Heinze A, Reichel G, Hefter H, Benecke R; Dysport myofascial pain study group. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain 2006;125:82-88
32. Turturro MA, Frater CR, D'Amico FJ. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial. Ann Emerg Med 2003;41:818-826
33. Raj PP, Paradise LA. Myofascial pain syndrome and its treatment in low back pain. Semin Pain Med 2004;2:167-174
34. Hou CR, Tsai LC, Cheng KF, Chung KC, Hong CZ. Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity. Arch Phys Med Rehabil 2002;83:1406-1414
35. Irnich D, Behrens N, Moizen H, König A, Gleditsch J, Krauss M, et al. Randomised trial of acupuncture compared with conventional massage and "sham" laser acupuncture for treatment of chronic neck pain. BMJ 2001 ;322(7302):1574-1578
36. Malanga GA, Gwynn MW, Smith R, Miller D. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician 2002;5:422-432